Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion type Assertion NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_head.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion description "[Current clinically available anti-HER2 therapies are effective only in patients with HER2 amplified breast cancer, including IBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion evidence source_evidence_literature NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion SIO_000772 24886365 NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion wasDerivedFrom befree-2016 NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.
- NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_assertion wasGeneratedBy ECO_0000203 NP1187755.RA6R_ObmwRZo7AmJvvIfeB1YLPKgmHp56EATnSp4AolDY130_provenance.